Research roundup

Debbie Rigby takes a look at the latest research relevant to pharmacists from around the world Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia Using a large U.K. primary care database, researchers have analysed the risks and benefits of newer diabetes drugs, including glitazones and gliptins. The risk of hyperglycaemia

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Ramadan with diabetes: pharmacists need training
Next Cold tablet double (or even triple) recording?